Spire Healthcare Group plc (LON:SPI – Get Free Report) shares hit a new 52-week high during trading on Monday. The stock traded as high as GBX 249.50 and last traded at GBX 248, with a volume of 60,433 shares traded. The stock had previously closed at GBX 248.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada lowered Spire Healthcare Group to a “sector perform” rating and decreased their price target for the stock from GBX 300 to GBX 250 in a research report on Monday, September 7th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Spire Healthcare Group currently has an average rating of “Moderate Buy” and an average target price of GBX 247.50.
Read Our Latest Analysis on SPI
Spire Healthcare Group Price Performance
The firm has a fifty day moving average price of GBX 242.42 and a 200 day moving average price of GBX 215.92. The company has a quick ratio of 0.73, a current ratio of 0.58 and a debt-to-equity ratio of 180.14. The company has a market cap of £991.48 million, a P/E ratio of -495.00, a PEG ratio of 1.06 and a beta of 0.93.
Spire Healthcare Group (LON:SPI – Get Free Report) last announced its earnings results on Wednesday, September 30th. The company reported GBX (0.50) earnings per share for the quarter. Spire Healthcare Group had a negative net margin of 0.12% and a negative return on equity of 0.26%. Equities research analysts forecast that Spire Healthcare Group plc will post 15.66 earnings per share for the current year.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Recommended Stories
- Five stocks we like better than Spire Healthcare Group
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
